205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-9.23%
Revenue decline while MCHP shows 0.07% growth. Joel Greenblatt would examine competitive position erosion.
-6.50%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
-17.32%
Gross profit decline while MCHP shows 0.22% growth. Joel Greenblatt would examine competitive position.
-8.91%
Margin decline while MCHP shows 0.15% expansion. Joel Greenblatt would examine competitive position.
-13.11%
R&D reduction while MCHP shows 7.99% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.49%
Operating expenses reduction while MCHP shows 0.32% growth. Joel Greenblatt would examine advantage.
-10.32%
Total costs reduction while MCHP shows 0.03% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
5.62%
D&A growth while MCHP reduces D&A. John Neff would investigate differences.
53.06%
EBITDA growth while MCHP declines. John Neff would investigate advantages.
68.62%
EBITDA margin growth while MCHP declines. John Neff would investigate advantages.
17.79%
Operating income growth exceeding 1.5x MCHP's 0.15%. David Dodd would verify competitive advantages.
9.43%
Operating margin growth exceeding 1.5x MCHP's 0.08%. David Dodd would verify competitive advantages.
-47.62%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
12.89%
Pre-tax income growth exceeding 1.5x MCHP's 1.03%. David Dodd would verify competitive advantages.
4.03%
Pre-tax margin growth exceeding 1.5x MCHP's 0.97%. David Dodd would verify competitive advantages.
-79.66%
Tax expense reduction while MCHP shows 1.03% growth. Joel Greenblatt would examine advantage.
40.61%
Net income growth exceeding 1.5x MCHP's 1.03%. David Dodd would verify competitive advantages.
34.57%
Net margin growth exceeding 1.5x MCHP's 0.97%. David Dodd would verify competitive advantages.
36.36%
EPS growth while MCHP declines. John Neff would investigate advantages.
36.36%
Diluted EPS growth while MCHP declines. John Neff would investigate advantages.
-6.67%
Share count reduction while MCHP shows 0.65% change. Joel Greenblatt would examine strategy.
-6.67%
Both companies reducing diluted shares. Martin Whitman would check patterns.